These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 28506728

  • 21. Combination therapy of inhaled steroids and long-acting beta2-agonists in asthma-COPD overlap syndrome.
    Lee SY, Park HY, Kim EK, Lim SY, Rhee CK, Hwang YI, Oh YM, Lee SD, Park YB.
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2797-2803. PubMed ID: 27877033
    [Abstract] [Full Text] [Related]

  • 22. [Community-acquired pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids or other bronchodilators. Study PNEUMOCORT].
    Morros R, Vedia C, Giner-Soriano M, Casellas A, Amado E, Baena JM, en representación de los investigadores del proyecto PNEUMOCORT.
    Aten Primaria; 2019; 51(6):333-340. PubMed ID: 29661670
    [Abstract] [Full Text] [Related]

  • 23. Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial.
    Watz H, Tetzlaff K, Wouters EF, Kirsten A, Magnussen H, Rodriguez-Roisin R, Vogelmeier C, Fabbri LM, Chanez P, Dahl R, Disse B, Finnigan H, Calverley PM.
    Lancet Respir Med; 2016 May; 4(5):390-8. PubMed ID: 27066739
    [Abstract] [Full Text] [Related]

  • 24. Inhaled treatment of COPD: a Delphi consensus statement.
    Ninane V, Corhay JL, Germonpré P, Janssens W, Joos GF, Liistro G, Vincken W, Gurdain S, Vanvlasselaer E, Lehouck A.
    Int J Chron Obstruct Pulmon Dis; 2017 May; 12():793-801. PubMed ID: 28293106
    [Abstract] [Full Text] [Related]

  • 25. Withdrawal of inhaled corticosteroids in people with COPD in primary care: a randomised controlled trial.
    Choudhury AB, Dawson CM, Kilvington HE, Eldridge S, James WY, Wedzicha JA, Feder GS, Griffiths CJ.
    Respir Res; 2007 Dec 27; 8(1):93. PubMed ID: 18162137
    [Abstract] [Full Text] [Related]

  • 26. Treatment trends in patients with asthma-COPD overlap syndrome in a COPD cohort: findings from a real-world survey.
    Ding B, Small M.
    Int J Chron Obstruct Pulmon Dis; 2017 Dec 27; 12():1753-1763. PubMed ID: 28670116
    [Abstract] [Full Text] [Related]

  • 27. Effects of roflumilast in COPD patients receiving inhaled corticosteroid/long-acting β2-agonist fixed-dose combination: RE(2)SPOND rationale and study design.
    Rennard SI, Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Siddiqui S, Anzueto A, Zhu H.
    Int J Chron Obstruct Pulmon Dis; 2016 Dec 27; 11():1921-8. PubMed ID: 27574416
    [Abstract] [Full Text] [Related]

  • 28. The dose of inhaled corticosteroids in patients with COPD: when less is better.
    Izquierdo JL, Cosio BG.
    Int J Chron Obstruct Pulmon Dis; 2018 Dec 27; 13():3539-3547. PubMed ID: 30498343
    [Abstract] [Full Text] [Related]

  • 29. [Corticosteroids for treatment of patients with chronic obstructive pulmonary disease].
    Nishimura K.
    Nihon Rinsho; 2003 Dec 27; 61(12):2181-6. PubMed ID: 14674330
    [Abstract] [Full Text] [Related]

  • 30. Inhaled corticosteroids and mortality in COPD.
    Macie C, Wooldrage K, Manfreda J, Anthonisen NR.
    Chest; 2006 Sep 27; 130(3):640-6. PubMed ID: 16963657
    [Abstract] [Full Text] [Related]

  • 31. Effects of inhaled corticosteroids in stable chronic obstructive pulmonary disease.
    Glaab T, Taube C.
    Pulm Pharmacol Ther; 2011 Feb 27; 24(1):15-22. PubMed ID: 20816832
    [Abstract] [Full Text] [Related]

  • 32. [Acute exacerbation in COPD and asthma].
    Yıldırım N, Demir T, Gemicioğlu B, Kıyan E, Oğuzülgen K, Polatlı M, Saryal S, Sayıner A, Yorgancıoğlu A, Bavbek S, Çelik GE, Günen H, Mungan D, Şen E, Türktaş H, Yıldız F.
    Tuberk Toraks; 2015 Jun 27; 63(2):111-31. PubMed ID: 26167969
    [Abstract] [Full Text] [Related]

  • 33. Inhaled steroids and COPD.
    Cooper CB, Decramer M.
    Eur Respir J; 2008 Aug 27; 32(2):523-4. PubMed ID: 18669794
    [No Abstract] [Full Text] [Related]

  • 34. Quality of life and adherence to inhaled corticosteroids and tiotropium in COPD are related.
    Koehorst-Ter Huurne K, Kort S, van der Palen J, van Beurden WJ, Movig KL, van der Valk P, Brusse-Keizer M.
    Int J Chron Obstruct Pulmon Dis; 2016 Aug 27; 11():1679-88. PubMed ID: 27555758
    [Abstract] [Full Text] [Related]

  • 35. Switching treatments in COPD: implications for costs and treatment adherence.
    Braido F, Lavorini F, Blasi F, Baiardini I, Canonica GW.
    Int J Chron Obstruct Pulmon Dis; 2015 Aug 27; 10():2601-8. PubMed ID: 26664108
    [Abstract] [Full Text] [Related]

  • 36. [The role of steroids in the treatment of COPD].
    Reynard C.
    Rev Med Suisse; 2007 Feb 21; 3(99):457-8, 460-1. PubMed ID: 17424796
    [Abstract] [Full Text] [Related]

  • 37. Anti-inflammatory effects of inhaled corticosteroids in chronic obstructive pulmonary disease: similarities and differences to asthma.
    Jeffery P.
    Expert Opin Investig Drugs; 2005 May 21; 14(5):619-32. PubMed ID: 15926868
    [Abstract] [Full Text] [Related]

  • 38. Inhaled Corticosteroids in COPD: Trying to Make a Long Story Short.
    Tantucci C, Pini L.
    Int J Chron Obstruct Pulmon Dis; 2020 May 21; 15():821-829. PubMed ID: 32368028
    [Abstract] [Full Text] [Related]

  • 39. Corticosteroids and chronic obstructive pulmonary disease in the nursing home.
    Rich A.
    J Am Med Dir Assoc; 2005 May 21; 6(3 Suppl):S68-74. PubMed ID: 15890302
    [No Abstract] [Full Text] [Related]

  • 40. Inhaled corticosteroids in chronic obstructive pulmonary disease and risk of death and hospitalization: time-dependent analysis.
    Fan VS, Bryson CL, Curtis JR, Fihn SD, Bridevaux PO, McDonell MB, Au DH.
    Am J Respir Crit Care Med; 2003 Dec 15; 168(12):1488-94. PubMed ID: 14525798
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.